Table 2.
Etiology | n(%) | ||
---|---|---|---|
IHD- HF | 180 (62.7) | ||
NIHD- HF n-107 (37.3%) | a-dilated cardiomyopathy | 36 (12.6) | |
b-valvular heart disease | 21 (7.4) | ||
c- HFpEF | 1-hypertensive heart disease | 13 (4.5) | |
2-Hypertrophic cardiomyopathy | 6 (2.1) | ||
d- Cor pulmonale | 13 (4.5) | ||
e- Chemotherapy induced | 6 (2.1) | ||
f- Primary PAH | 6 (2.1) | ||
g- Restrictive cardiomyopathy | 3 (1.0) | ||
h- Congenital heart disease | 3 (1.0) | ||
Total | 287 (100) |